Xtant Medical Holdings Profit Margin

The latest profit margin for XTNT is -10.17% as of June 2026. That compares with -3.59% in the prior-year period — down 183.6% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Xtant Medical Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, XTNT's profit margin moved from -3.59% to -10.17% — a 183.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xtant Medical Holdings's valuation or profitability profile.

Against Healthcare companies, XTNT currently prints -10.17% for profit margin, while the sector average sits near 21.34%. That is roughly 147.7% below the sector mean. Large gaps often invite a closer look at Xtant Medical Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Xtant Medical Holdings converts resources into returns. At -10.17%, XTNT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3.59% in the prior-year period — down 183.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting XTNT's profit margin (-10.17%), review year-over-year change from -3.59%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.